Virtual Engineering Week 2020 is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Virtual Engineering Week Schedule Viewer


Virtual Engineering Week is bringing a full week of best-in-class education to the global design, engineering, and manufacturing communities. Join us each morning to hear from medical device industry professionals during the Medtech Mornings series, and in the afternoons to learn from engineering and manufacturing experts in areas like 3D printing, smart manufacturing, packaging, materials and sustainability, and career development.

All times listed below are PST (Pacific Standard Time).

Ethylene Oxide Sterilization: An FDA & EPA Update

Mac McKeen  (Fellow, Regulatory Science, Boston Scientific)

Date: Wednesday, December 2

Time: 9:00am - 9:30am

Track: MedTech Mornings: Medical Packaging

Vault Recording: TBD

Due to the EPA shut down of a number of contract sterilizer facilities, the FDA has established a major initiative and focus on reducing the amount of EtO used to sterilize medical devices and address the issue of Fugitive Emissions as the EPA is imposing a proposed rule to strictly limit the EtO emissions from sterilization facilities. With the sterilization network operating at near capacity in the US this has impacted and continues to threaten the availability of medical products to the US healthcare system and patients that presents new and unprecedented regulatory challenges. In a very unique and remarkably proactive manner, the FDA is enacting streamlined regulatory processes to reduce the risk of shortages and encourage companies to reduce the amount of EtO used in their sterilization cycles. As a result of this high profile issue in the US, the EU MDR also introduces challenges for the company to manage the timing of changes to the cycle within the strict deadlines and transition timelines that have an impact on a Global scale.

Topics covered include:
  • An analysis of the FDA efforts to reduce EtO emissions
  • How companies can develop methodologies to validate lower EtO gas concentrations
  • Ways to engage regulators without disrupting the sterilization supply chain and network